Table 2. Results of time-varying cox regression models for stroke in the eligible population.
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
| Time-varying Covariate | |||
| Cranial Nerve Palsy | 4.65 (3.73–5.79) | 2.21 (1.77–2.75) | 1.70 (1.37–2.12) |
| Demographics | |||
| Sex | |||
| Men | N/A | 1 (reference) | 1 (reference) |
| Women | N/A | 0.73 (0.71–0.75) | 0.72 (0.70–0.74) |
| Age Group (years) | |||
| 20–39 | N/A | 1 (reference) | 1 (reference) |
| 40–59 | N/A | 6.01 (5.64–6.40) | 4.26 (3.99–4.54) |
| 60+ | N/A | 31.85 (29.98–33.83) | 15.11 (14.15–16.13) |
| Residence | |||
| Seoul and Incheon | N/A | 1 (reference) | 1 (reference) |
| Gyeonggi and Gangwon | N/A | 1.16 (1.10–1.21) | 1.14 (1.09–1.19) |
| Busan, Daegu, Ulsan, and Gyeongsang | N/A | 1.32 (1.26–1.38) | 1.38 (1.32–1.44) |
| Daejeon, Sejong, and Chungcheong | N/A | 1.26 (1.19–1.32) | 1.26 (1.19–1.33) |
| Gwangju, Jeola, and Jeju | N/A | 1.25 (1.19–1.31) | 1.27 (1.21–1.34) |
| House Income | |||
| Low income | N/A | 1 (reference) | 1 (reference) |
| Middle income | N/A | 0.92 (0.89–0.96) | 0.89 (0.86–0.92) |
| High income | N/A | 0.88 (0.85–0.91) | 0.83 (0.80–0.86) |
| Covariates | |||
| Hypertension | N/A | N/A | 2.52 (2.42–2.62) |
| Diabetes | N/A | N/A | 1.29 (1.24–1.33) |
| Ischemic Heart Disease | N/A | N/A | 1.11 (1.07–1.16) |
| Congestive Heart Failure | N/A | N/A | 1.29 (1.23–1.35) |
| Cancer | N/A | N/A | 1.00 (0.95–1.04) |
| Tuberculosis | N/A | N/A | 1.02 (0.95–1.08) |
| Peripheral Arterial Disease | N/A | N/A | 1.15 (1.11–1.20) |
| Atrial Fibrillation | N/A | N/A | 1.79 (1.68–1.91) |
| Chronic Kidney Disease | N/A | N/A | 1.55 (1.42–1.70) |
| Dyslipidemia | N/A | N/A | 0.93 (0.89–0.96) |
| Co-medications | |||
| Anti-coagulant agents | N/A | N/A | 1.11 (0.89–1.39) |
| Anti-hypertensive agents | N/A | N/A | 0.91 (0.87–0.95) |
| Anti-platelet agents | N/A | N/A | 1.03 (0.93–1.14) |
| Hypoglycemic agents | N/A | N/A | 2.57 (0.83–7.96) |
Model 3 included Charlson comorbidity index in the analysis